SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-058742
Filing Date
2018-09-26
Accepted
2018-09-26 16:16:45
Documents
1
Period of Report
2018-09-25

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4957
  Complete submission text file 0001104659-18-058742.txt   6332
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address SCOPIA CAPITAL MANAGEMENT LP 152 WEST 57TH STREET, 33RD FLOOR NEW YORK NY 10019
Business Address
TYAGI ASHU (Reporting) CIK: 0001752467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 181088102